Knee Replacement Surgery Market - Global Forecast to 2030
商品番号 : SMB-82903
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年7月 |
| ページ数 | 270 |
| 図表数 | 333 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
この市場調査レポートは、膝関節置換手術市場を、手術の種類、製品、用途、エンドユーザー、地域といった複数のセグメントに沿って分析しています。さらに、市場の成長を牽引する要因を明らかにし、機会と脅威について言及し、主要企業の競争状況を分析しています。さらに、成長傾向に焦点を当ててミクロ市場を分析し、主要5地域および対応する国における業界セグメントの収益予測も示しています。
The global knee replacement surgery market is expected to reach USD 16.17 billion by 2030 from USD 12.00 billion in 2025, at a CAGR of 6.1% from 2025 to 2030. The Knee replacement surgery market is witnessing substantial growth driven by several key factors. A heightened awareness of various treatment modalities, coupled with improved healthcare infrastructure in developing regions, is facilitating an increase in surgical procedures. Additionally, government initiatives and insurance reforms are enhancing both the affordability and accessibility of knee surgeries, further propelling market activity. Notably, the rising incidence of sports-related injuries among the younger population is contributing to the premature onset of knee conditions, thereby expanding the patient demographic that requires surgical intervention. Collectively, these factors are catalyzing the expansion of the global knee replacement surgery market.
世界の膝関節置換手術市場は、2025年の120億米ドルから2030年には161億7,000万米ドルに達し、2025年から2030年にかけて6.1%のCAGRで成長すると予想されています。膝関節置換手術市場は、いくつかの重要な要因に牽引され、大幅な成長を遂げています。さまざまな治療法に対する認識の高まりと、発展途上地域における医療インフラの改善が相まって、外科手術の増加を促進しています。さらに、政府の取り組みと保険改革により、膝関節手術の費用対効果とアクセス性が向上し、市場活動がさらに促進されています。特に、若年層におけるスポーツ関連の負傷の発生率の上昇が、膝の疾患の早期発症の一因となっており、外科的介入を必要とする患者層が拡大しています。これらの要因が相まって、世界の膝関節置換手術市場の拡大を促進しています。
“The total knee replacement segment held the largest procedure type market share in 2024.”
The knee replacement surgery market is divided into total knee replacement, partial knee replacement, revision knee replacement, and other procedure types. In 2024, the total knee replacement (TKR) segment is projected to dominate the market, primarily driven by the rising prevalence of osteoarthritis, particularly within the geriatric population. This trend underscores the growing demand for durable and effective therapeutic interventions such as TKR. Furthermore, enhanced healthcare infrastructure and increasing awareness of treatment options have facilitated broader accessibility to knee implants in both developed and emerging economies.
“The osteoarthritis & rheumatoid arthritis segment commanded the largest applications market share in 2024.”
The knee replacement surgery market is segmented by application: osteoarthritis & rheumatoid arthritis, degenerative disease, cancers, and other applications. In 2024, the osteoarthritis & rheumatoid arthritis segment held the major share. Degenerative joint diseases and inflammatory conditions, such as arthritis, can be exacerbated during their initial stages due to sedentary behavior, suboptimal postural alignment, and mechanical stress on the joints resulting from routine activities.
“The knee implants segment held the largest product market share in 2024.”
The knee implants segment represents the predominant share of the knee replacement surgery market. These implants are pivotal in enhancing patients’ quality of life by providing long-lasting analgesia and restoring joint mobility. Their preference among orthopedic surgeons and patients alike can be attributed to their high success and satisfaction rates. Continuous advancements in materials—such as biocompatible alloys and polymers—coupled with innovative design enhancements and superior fixation techniques, have increased the reliability and longevity of these implants. Consequently, there has been a notable uptick in their adoption across various clinical settings.
“The hospitals segment accounted for the largest end user market share in 2024.”
Hospitals command the largest market share in knee treatment surgical products due to their central role in providing advanced and specialized interventions for knee pathologies. They are equipped to perform cutting-edge procedures, such as total knee arthroplasty, positioning themselves as the preferred venues for orthopedic surgeries. Furthermore, hospitals typically have the financial resources and infrastructure necessary to handle complex cases, execute minimally invasive techniques, and deliver comprehensive postoperative care, all of which contribute to sustained demand for knee treatment surgical devices.
“The Asia Pacific market is expected to register the highest growth rate during the forecast period.”
The knee replacement surgery market covers five key geographies—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, a significant market share for knee treatment surgery devices was held by the market in the North American region, comprising the US and Canada. On the other hand, the Asia Pacific market is estimated to register the highest growth rate during the forecast period. The Asia Pacific region is witnessing unprecedented expansion in the market for knee treatment surgical devices, driven by several key factors. The demographic shift towards an aging population is significant, with increased prevalence of musculoskeletal disorders such as arthritis and osteoporosis particularly evident in nations like Japan, China, and India. This demographic change is compounded by rising disposable incomes and improved access to healthcare services. The region’s healthcare infrastructure is rapidly evolving, with investments in advanced technologies such as minimally invasive surgical techniques and robotic-assisted procedures, which are enhancing surgical outcomes and patient recovery times. Moreover, the surge in medical tourism, particularly in India and Thailand, along with proactive government initiatives aimed at bolstering healthcare infrastructure, further catalyzes market growth. These dynamics collectively position the Asia Pacific as a pivotal market for advancements in orthopedic treatment devices.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1– 30%, Tier 2– 42%, and Tier 3– 28%
- By Designation: Directors– 10%, Managers– 14%, and Others– 76%
- By Region: North America– 40%, Europe– 30%, Asia Pacific– 22%, Latin America- 6%, Middle East & Africa- 2%
The prominent players in the Knee replacement surgery market are Stryker (US), Johnson & Johnson Services, Inc. (US), Globus Medical, Inc. (US), Medacta International SA (Switzerland), Zimmer Biomet (US), Maxx Orthopedics (US), Enovis Corporation (US), Microport Scientific Corporation (China), B. Braun Melsungen AG (Germany), Meril Life Sciences Pvt. Ltd. (India), Smith & Nephew PLC (UK), and Exactech Inc. (US)
Research Coverage
This market research report analyzes the knee replacement surgery market along several different segments, such as procedure type, product, application, end user, and region. The report further sheds light on market growth-driving factors, mentions opportunities and threats, and presents an analysis of the competitive rivalry of leading companies. It further studies micro markets by focusing on growth tendencies and predicts revenues for industry segments for five leading geographies, along with corresponding countries.
Reasons to Buy the Report
The report would assist both small and new businesses in comprehending the market pattern, which can help them grow their market. Businesses procuring the report can implement any one or several of the approaches discussed to extend their market position.
This report provides insights on the following pointers:
- Key drivers (increasing prevalence of osteoarthritis and rheumatoid arthritis, Increasing adoption of telemedicine and telesurgery, rising demand for minimally invasive procedures, increasing demand for minimally invasive knee surgical procedures, and higher incidence of sports and accident-related orthopedic injuries), restraints (risk and complications associated with knee surgery procedures, high cost of knee treatment surgery and treatments), opportunities (Growing focus on orthobiologics, increasing hospitals and trend towards outpatient care and innovations in robotic-assisted orthopedic surgeries and 3D printing), and challenges (dearth of orthopedic surgeons ) fueling the market growth of knee treatment surgery devices
- Product Development/Innovation: In-depth study of emerging technologies, R&D programs, and new product & service launches in the knee replacement surgery market
- Market Growth: In-depth insights into remunerative markets report analyze the knee replacement surgery market across varied geographies.
- Market Diversification: Detailed analysis of new products, unexplored geographies, latest trends, and investments in the knee replacement surgery market
- Competitive Analysis: In-depth analysis of market shares, growth strategies, and services of leading players, such as Zimmer Biomet (US), Stryker (US), Johnson & Johnson Services, Inc. (US), Smith+Nephew PLC (UK), and B. Braun (Germany).
Table of Contents
1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.3 STUDY SCOPE 27
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 27
1.3.2 INCLUSIONS AND EXCLUSIONS 28
1.3.3 YEARS CONSIDERED 28
1.4 CURRENCY CONSIDERED 29
1.5 STAKEHOLDERS 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DESIGN 30
2.2 RESEARCH DATA 31
2.2.1 SECONDARY RESEARCH 32
2.2.1.1 Key data from secondary sources 33
2.2.2 PRIMARY RESEARCH 33
2.2.2.1 Primary sources 34
2.2.2.2 Key industry insights 35
2.3 MARKET SIZE ESTIMATION 36
2.3.1 BOTTOM-UP APPROACH 38
2.3.1.1 Approach 1: Company revenue estimation approach 38
2.3.1.2 Approach 2: Customer-based market estimation 39
2.3.1.3 Approach 3: Primary interviews 40
2.3.2 TOP-DOWN APPROACH 40
2.4 GROWTH FORECAST 40
2.5 DATA TRIANGULATION AND MARKET BREAKDOWN 42
2.6 MARKET SHARE ASSESSMENT 42
2.7 RESEARCH ASSUMPTIONS 43
2.8 RESEARCH LIMITATIONS 43
2.9 RISK ASSESSMENT 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 49
4.1 KNEE REPLACEMENT SURGERY MARKET OVERVIEW 49
4.2 NORTH AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT 50
4.3 EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE 50
4.4 ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY END USER 51
4.5 KNEE REPLACEMENT SURGERY MARKET, BY REGION 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
5.2.1 DRIVERS 53
5.2.1.1 Increasing prevalence of osteoarthritis and rheumatoid arthritis 53
5.2.1.2 Rising adoption of telemedicine and telesurgery 53
5.2.1.3 Growing demand for minimally invasive knee surgical procedures 54
5.2.1.4 Rise in sports and accident-related knee injuries 54
5.2.1.5 Booming geriatric population and subsequent age-related bone diseases 54
5.2.2 RESTRAINTS 55
5.2.2.1 Risks and complications associated with knee surgical procedures 55
5.2.2.2 High cost of knee replacement surgery products and treatments 55
5.2.3 OPPORTUNITIES 55
5.2.3.1 Growing focus on orthobiologics 55
5.2.3.2 Rising number of hospitals and shift toward outpatient care 56
5.2.3.3 Increasing use of robotics and 3D printing in knee replacement 56
5.2.4 CHALLENGES 57
5.2.4.1 Dearth of orthopedic surgeons 57
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 58
5.4 PRICING ANALYSIS 58
5.4.1 AVERAGE SELLING PRICE, BY PRODUCT 59
5.4.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 59
5.4.3 AVERAGE SELLING PRICE TREND, BY REGION 60
5.5 VALUE CHAIN ANALYSIS 61
5.5.1 RESEARCH & PRODUCT DEVELOPMENT 61
5.5.2 RAW MATERIAL PROCUREMENT 61
5.5.3 MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES 62
5.6 SUPPLY CHAIN ANALYSIS 63
5.6.1 MANUFACTURERS 63
5.6.1.1 Prominent companies 63
5.6.1.2 Small and medium-sized enterprises 63
5.6.2 END USERS 63
5.7 ECOSYSTEM ANALYSIS 64
5.8 INVESTMENT AND FUNDING SCENARIO 65
5.9 TECHNOLOGY ANALYSIS 66
5.9.1 KEY TECHNOLOGIES 66
5.9.1.1 3D printed implants/Additive manufacturing 66
5.9.2 COMPLEMENTARY TECHNOLOGIES 67
5.9.2.1 Robotic-assisted surgery 67
5.9.3 ADJACENT TECHNOLOGIES 67
5.9.3.1 Smart implants and sensors 67
5.10 PATENT ANALYSIS 68
5.11 TRADE ANALYSIS 69
5.11.1 IMPORT DATA FOR HS CODE 902110 69
5.11.2 EXPORT DATA FOR HS CODE 902110 70
5.12 KEY CONFERENCES AND EVENTS, 2025–2026 72
5.13 CASE STUDY ANALYSIS 73
5.13.1 CASE STUDY 1: ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION AND CHONDROPLASTY OF KNEE 73
5.13.2 CASE STUDY 2: BILATERAL TOTAL KNEE REPLACEMENT IN FUNCTIONALLY IMMOBILE PATIENT WITH TRICOMPARTMENTAL ARTHRITIS 73
5.13.3 CASE STUDY 3: RIGHT TOTAL KNEE ARTHROPLASTY FOR IMPROVED MOTION RANGE 74
5.14 PORTER’S FIVE FORCES ANALYSIS 74
5.14.1 BARGAINING POWER OF SUPPLIERS 75
5.14.2 BARGAINING POWER OF BUYERS 75
5.14.3 THREAT OF NEW ENTRANTS 76
5.14.4 THREAT OF SUBSTITUTES 76
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 76
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 76
5.15.1 KEY STAKEHOLDERS 76
5.15.2 KEY BUYING CRITERIA 77
5.16 UNMET NEEDS 78
5.17 IMPACT OF AI/GEN AI 78
5.17.1 INTRODUCTION 78
5.17.2 MARKET POTENTIAL OF AI ON KNEE REPLACEMENT SURGERY MARKET 78
5.17.3 AI USE CASES 79
5.17.4 KEY COMPANIES IMPLEMENTING AI 79
5.18 IMPACT OF 2025 US TARIFF 80
5.18.1 INTRODUCTION 80
5.18.2 KEY TARIFF RATES 80
5.18.3 PRICE IMPACT ANALYSIS 81
5.18.4 IMPACT ON COUNTRY/REGION 81
5.18.4.1 US 81
5.18.4.2 Europe 81
5.18.4.3 Asia Pacific 81
5.18.5 IMPACT ON END-USE INDUSTRIES 81
6 KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT 82
6.1 INTRODUCTION 83
6.2 KNEE IMPLANTS 83
6.2.1 HYBRID IMPLANTS 85
6.2.1.1 Long-term durability and strong initial fixation to contribute to growth 85
6.2.2 PLASTIC IMPLANTS 85
6.2.2.1 Rising number of joint surgeries to accelerate growth 85
6.2.3 METAL IMPLANTS 86
6.2.3.1 Growing need for long-lasting joint replacements to drive market 86
6.2.4 CERAMIC IMPLANTS 87
6.2.4.1 Minimal propensity to induce inflammation to facilitate growth 87
6.3 ORTHOBIOLOGICS 88
6.3.1 BONE MARROW ASPIRATE CONCENTRATE 88
6.3.1.1 Minimally invasive procedure and less downtime to foster growth 88
6.3.2 VISCOSUPPLEMENTATION PRODUCTS 89
6.3.2.1 Rising occurrence of osteoarthritis to favor growth 89
6.3.3 DEMINERALIZED BONE MATRIX 90
6.3.3.1 Suitability for intricate operations to facilitate growth 90
6.3.4 PLATELET-RICH PLASMA 91
6.3.4.1 Rising application of platelet-rich plasma in sports injuries to support growth 91
6.3.5 BONE MORPHOGENETIC PROTEINS 91
6.3.5.1 Essential role in joint reconstructive surgery to aid growth 91
6.4 KNEE BRACES & SUPPORT SYSTEMS 92
6.4.1 GROWING GERIATRIC AND OBESE POPULATIONS TO PROPEL MARKET 92
7 KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE 94
7.1 INTRODUCTION 95
7.2 TOTAL KNEE REPLACEMENT 96
7.2.1 ONGOING INNOVATIONS IN KNEE IMPLANTS TO EXPEDITE GROWTH 96
7.3 PARTIAL KNEE REPLACEMENT DEVICES 97
7.3.1 QUICK RECOVERY AND SHORTER HOSPITAL STAYS TO AID GROWTH 97
7.4 REVISION KNEE REPLACEMENT 97
7.4.1 RISING INCIDENCE OF OBESITY AND ADVANCEMENTS IN REVISION SURGICAL TECHNOLOGY TO FACILITATE GROWTH 97
7.5 OTHER KNEE REPLACEMENT PROCEDURES 98
8 KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION 100
8.1 INTRODUCTION 101
8.2 RHEUMATOID ARTHRITIS & OSTEOARTHRITIS 101
8.2.1 RISING POOL OF ELDERLY PATIENTS TO AUGMENT GROWTH 101
8.3 DEGENERATIVE DISEASES 102
8.3.1 GROWING IMPACT OF SECONDARY KNEE CONDITIONS TO DRIVE MARKET 102
8.4 CANCERS 103
8.4.1 GROWING BURDEN OF BONE CANCER TO PROPEL MARKET 103
8.5 OTHER APPLICATIONS 104
9 KNEE REPLACEMENT SURGERY MARKET, BY END USER 105
9.1 INTRODUCTION 106
9.2 HOSPITALS 106
9.2.1 GROWING INVESTMENTS IN HOSPITAL INFRASTRUCTURE TO BOOST MARKET 106
9.3 AMBULATORY SURGERY CENTERS 107
9.3.1 INCREASING PREFERENCE FOR COST-EFFECTIVE TREATMENT TO PROMOTE GROWTH 107
9.4 ORTHOPEDIC CLINICS 108
9.4.1 LIMITED HOSPITALIZATION TIME, LOWER COSTS, AND EFFECTIVE POST-OPERATIVE CARE TO SUPPORT GROWTH 108
10 KNEE REPLACEMENT SURGERY MARKET, BY REGION 110
10.1 INTRODUCTION 111
10.2 NORTH AMERICA 111
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 112
10.2.2 US 116
10.2.2.1 Increasing incidence of osteoarthritis and rheumatoid arthritis market to promote growth 116
10.2.3 CANADA 119
10.2.3.1 Rising incidence of degenerative bone diseases to support growth 119
10.3 EUROPE 122
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 122
10.3.2 GERMANY 126
10.3.2.1 Growing demand for advanced medical technology to drive market 126
10.3.3 FRANCE 129
10.3.3.1 Rising prevalence of musculoskeletal disorders to contribute to growth 129
10.3.4 UK 132
10.3.4.1 Increasing awareness of orthopedic conditions to favor growth 132
10.3.5 ITALY 135
10.3.5.1 Growing awareness of preventive care for musculoskeletal injuries to fuel market 135
10.3.6 SPAIN 137
10.3.6.1 Rising preference for minimally invasive surgical procedures to aid growth 137
10.3.7 REST OF EUROPE 140
10.4 ASIA PACIFIC 143
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 144
10.4.2 JAPAN 149
10.4.2.1 Rapidly growing geriatric population to boost market 149
10.4.3 CHINA 152
10.4.3.1 Expanding target patient population to fuel market 152
10.4.4 INDIA 155
10.4.4.1 Increasing number of hospitals adopting robotic-assisted joint replacement surgery to aid growth 155
10.4.5 AUSTRALIA 158
10.4.5.1 Favorable government and private initiatives to promote growth 158
10.4.6 SOUTH KOREA 161
10.4.6.1 Increasing research & development funding to spur growth 161
10.4.7 REST OF ASIA PACIFIC 164
10.5 LATIN AMERICA 167
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 167
10.5.2 BRAZIL 171
10.5.2.1 Strong presence of global players to drive market 171
10.5.3 MEXICO 174
10.5.3.1 Favorable investment scenario for medical device manufacturers to bolster growth 174
10.5.4 REST OF LATIN AMERICA 177
10.6 MIDDLE EAST & AFRICA 180
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 180
10.6.2 GCC COUNTRIES 184
10.6.2.1 Growing public-private partnerships to propel market 184
10.6.3 REST OF MIDDLE EAST & AFRICA 187
11 COMPETITIVE LANDSCAPE 191
11.1 OVERVIEW 191
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 191
11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES 192
11.3 REVENUE ANALYSIS, 2021−2024 193
11.4 MARKET SHARE ANALYSIS, 2024 194
11.5 COMPANY VALUATION AND FINANCIAL METRICS 196
11.6 BRAND/PRODUCT COMPARISON 197
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 198
11.7.1 STARS 198
11.7.2 EMERGING LEADERS 198
11.7.3 PERVASIVE PLAYERS 198
11.7.4 PARTICIPANTS 198
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 200
11.7.5.1 Company footprint 200
11.7.5.2 Region footprint 201
11.7.5.3 Product footprint 201
11.7.5.4 Application footprint 202
11.7.5.5 Procedure footprint 203
11.7.5.6 End-user footprint 203
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 204
11.8.1 PROGRESSIVE COMPANIES 204
11.8.2 RESPONSIVE COMPANIES 204
11.8.3 DYNAMIC COMPANIES 204
11.8.4 STARTING BLOCKS 204
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 206
11.8.5.1 Detailed list of key startups/SMEs 206
11.8.5.2 Competitive benchmarking of key startups/SMEs 207
11.9 COMPETITIVE SCENARIO 208
11.9.1 PRODUCT LAUNCHES AND APPROVALS 208
11.9.2 DEALS 209
12 COMPANY PROFILES 211
12.1 KEY PLAYERS 211
12.1.1 ZIMMER BIOMET 211
12.1.1.1 Business overview 211
12.1.1.2 Products offered 212
12.1.1.3 Recent developments 213
12.1.1.3.1 Product launches and approvals 213
12.1.1.3.2 Deals 214
12.1.1.4 MnM view 214
12.1.1.4.1 Key strengths 214
12.1.1.4.2 Strategic choices 214
12.1.1.4.3 Weaknesses and competitive threats 214
12.1.2 STRYKER 215
12.1.2.1 Business overview 215
12.1.2.2 Products offered 216
12.1.2.3 Recent developments 217
12.1.2.3.1 Deals 217
12.1.2.3.2 Expansions 217
12.1.2.4 MnM view 218
12.1.2.4.1 Key strengths 218
12.1.2.4.2 Strategic choices 218
12.1.2.4.3 Weaknesses and competitive threats 218
12.1.3 JOHNSON & JOHNSON MEDTECH 219
12.1.3.1 Business overview 219
12.1.3.2 Products offered 220
12.1.3.3 Recent developments 221
12.1.3.3.1 Deals 221
12.1.3.4 MnM view 221
12.1.3.4.1 Key strengths 221
12.1.3.4.2 Strategic choices 221
12.1.3.4.3 Weaknesses and competitive threats 221
12.1.4 SMITH+NEPHEW 222
12.1.4.1 Business overview 222
12.1.4.2 Products offered 223
12.1.4.3 Recent developments 224
12.1.4.3.1 Product launches and approvals 224
12.1.4.3.2 Deals 224
12.1.4.3.3 Expansions 224
12.1.4.4 MnM view 225
12.1.4.4.1 Key strengths 225
12.1.4.4.2 Strategic choices 225
12.1.4.4.3 Weaknesses and competitive threats 225
12.1.5 B. BRAUN SE 226
12.1.5.1 Business overview 226
12.1.5.2 Products offered 227
12.1.5.3 Recent developments 228
12.1.5.3.1 Deals 228
12.1.5.4 MnM view 228
12.1.5.4.1 Key strengths 228
12.1.5.4.2 Strategic choices 228
12.1.5.4.3 Weaknesses and competitive threats 229
12.1.6 GLOBUS MEDICAL 230
12.1.6.1 Business overview 230
12.1.6.2 Products offered 231
12.1.6.3 Recent developments 232
12.1.6.3.1 Product launches and approvals 232
12.1.6.3.2 Deals 232
12.1.7 ENOVIS 233
12.1.7.1 Business overview 233
12.1.7.2 Products offered 234
12.1.7.3 Recent developments 236
12.1.7.3.1 Product launches and approvals 236
12.1.7.3.2 Deals 236
12.1.7.3.3 Expansions 237
12.1.8 MICROPORT SCIENTIFIC CORPORATION 238
12.1.8.1 Business overview 238
12.1.8.2 Products offered 239
12.1.8.3 Recent developments 240
12.1.8.3.1 Deals 240
12.1.9 MEDACTA INTERNATIONAL 241
12.1.9.1 Business overview 241
12.1.9.2 Products offered 242
12.1.9.3 Recent developments 243
12.1.9.3.1 Deals 243
12.1.9.3.2 Expansions 243
12.1.10 MAXX ORTHOPEDICS, INC. 244
12.1.10.1 Business overview 244
12.1.10.2 Products offered 244
12.1.10.3 Recent developments 244
12.1.10.3.1 Product launches and approvals 244
12.1.10.3.2 Deals 245
12.1.11 MERIL LIFE SCIENCES PVT. LTD. 246
12.1.11.1 Business overview 246
12.1.11.2 Products offered 246
12.1.11.3 Recent developments 247
12.1.11.3.1 Expansions 247
12.1.12 WALDEMAR LINK GMBH & CO. KG 248
12.1.12.1 Business overview 248
12.1.12.2 Products offered 248
12.1.13 EXACTECH, INC. 249
12.1.13.1 Business overview 249
12.1.13.2 Products offered 249
12.1.13.3 Recent developments 250
12.1.13.3.1 Product launches and approvals 250
12.1.13.3.2 Deals 250
12.1.14 AMPLITUDE SURGICAL 251
12.1.14.1 Business overview 251
12.1.14.2 Products offered 251
12.1.14.3 Recent developments 252
12.1.14.3.1 Deals 252
12.1.15 RESTOR3D 253
12.1.15.1 Business overview 253
12.1.15.2 Products offered 253
12.1.15.3 Recent developments 253
12.1.15.3.1 Product launches and approvals 253
12.2 OTHER PLAYERS 254
12.2.1 BAUERFEIND 254
12.2.2 AK MEDICAL 255
12.2.3 DOUBLE MEDICAL TECHNOLOGY INC. 256
12.2.4 OLYMPUS CORPORATION 257
12.2.5 BIORAD MEDISYS PVT. LTD. 258
12.2.6 UNITED ORTHOPEDIC CORPORATION 259
12.2.7 ALLEGRA 260
12.2.8 TOTAL JOINT ORTHOPEDICS 260
12.2.9 THUASNE GROUP 261
12.2.10 EMBLA MEDICAL 262
13 APPENDIX 263
13.1 DISCUSSION GUIDE 263
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 266
13.3 CUSTOMIZATION OPTIONS 268
13.4 RELATED REPORTS 268
13.5 AUTHOR DETAILS 269
LIST OF TABLES
TABLE 1 KNEE REPLACEMENT SURGERY MARKET: INCLUSIONS AND EXCLUSIONS 28
TABLE 2 KNEE REPLACEMENT SURGERY MARKET: RISK ASSESSMENT 44
TABLE 3 AVERAGE SELLING PRICE TREND OF KNEE IMPLANTS, BY KEY PLAYER,
2022–2024 (USD) 59
TABLE 4 AVERAGE SELLING PRICE TREND OF KNEE SURGERY PRODUCTS, BY REGION, 2022–2024 (USD) 61
TABLE 5 KNEE REPLACEMENT SURGERY MARKET: ROLE OF COMPANIES IN ECOSYSTEM 65
TABLE 6 KNEE REPLACEMENT SURGERY MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2025 69
TABLE 7 IMPORT DATA FOR HS CODE 902110, BY COUNTRY,
2021–2024 (USD THOUSAND) 70
TABLE 8 EXPORT DATA FOR HS CODE 902110, BY COUNTRY,
2021–2024 (USD THOUSAND) 71
TABLE 9 KNEE REPLACEMENT SURGERY MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 72
TABLE 10 KNEE REPLACEMENT SURGERY MARKET: PORTER’S FIVE FORCES ANALYSIS 74
TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%) 77
TABLE 12 KEY BUYING CRITERIA, BY END USER 77
TABLE 13 KNEE REPLACEMENT SURGERY MARKET: UNMET NEEDS 78
TABLE 14 KNEE REPLACEMENT SURGERY MARKET: COMPANIES IMPLEMENTING AI 79
TABLE 15 US ADJUSTED RECIPROCAL TARIFF RATES 80
TABLE 16 KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 83
TABLE 17 KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 84
TABLE 18 KNEE IMPLANTS MARKET, BY REGION, 2023–2030 (USD MILLION) 84
TABLE 19 HYBRID IMPLANTS MARKET, BY REGION, 2023–2030 (USD MILLION) 85
TABLE 20 PLASTIC IMPLANTS MARKET, BY REGION, 2023–2030 (USD MILLION) 86
TABLE 21 METAL IMPLANTS MARKET, BY REGION, 2023–2030 (USD MILLION) 86
TABLE 22 CERAMIC IMPLANTS MARKET, BY REGION, 2023–2030 (USD MILLION) 87
TABLE 23 ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 88
TABLE 24 BONE MARROW ASPIRATE CONCENTRATE MARKET, BY REGION,
2023–2030 (USD MILLION) 89
TABLE 25 VISCOSUPPLEMENTATION PRODUCTS MARKET, BY REGION,
2023–2030 (USD MILLION) 90
TABLE 26 DEMINERALIZED BONE MATRIX MARKET, BY REGION, 2023–2030 (USD MILLION) 90
TABLE 27 PLATELET-RICH PLASMA MARKET, BY REGION, 2023–2030 (USD MILLION) 91
TABLE 28 BONE MORPHOGENETIC PROTEINS MARKET, BY REGION,
2023–2030 (USD MILLION) 92
TABLE 29 KNEE BRACES & SUPPORT SYSTEMS MARKET, BY REGION,
2023–2030 (USD MILLION) 93
TABLE 30 KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 95
TABLE 31 KNEE REPLACEMENT SURGERY MARKET, BY REGION, 2023–2030 (USD MILLION) 95
TABLE 32 KNEE REPLACEMENT SURGERY PROCEDURES, BY REGION,
2022–2024 (VOLUME UNIT) 96
TABLE 33 TOTAL KNEE REPLACEMENT PROCEDURES MARKET, BY REGION,
2023–2030 (USD MILLION) 96
TABLE 34 PARTIAL KNEE REPLACEMENT PROCEDURES MARKET, BY REGION,
2023–2030 (USD MILLION) 97
TABLE 35 REVISION KNEE REPLACEMENT PROCEDURES MARKET, BY REGION,
2023–2030 (USD MILLION) 98
TABLE 36 OTHER KNEE REPLACEMENT PROCEDURES MARKET, BY REGION,
2023–2030 (USD MILLION) 99
TABLE 37 KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 101
TABLE 38 KNEE REPLACEMENT SURGERY MARKET FOR RHEUMATOID ARTHRITIS & OSTEOARTHRITIS, BY REGION, 2023–2030 (USD MILLION) 102
TABLE 39 KNEE REPLACEMENT SURGERY MARKET FOR DEGENERATIVE DISEASES,
BY REGION, 2023–2030 (USD MILLION) 103
TABLE 40 KNEE REPLACEMENT SURGERY MARKET FOR CANCERS, BY REGION,
2023–2030 (USD MILLION) 104
TABLE 41 KNEE REPLACEMENT SURGERY MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 104
TABLE 42 KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 106
TABLE 43 KNEE REPLACEMENT SURGERY MARKET FOR HOSPITALS, BY REGION,
2023–2030 (USD MILLION) 107
TABLE 44 KNEE REPLACEMENT SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2023–2030 (USD MILLION) 108
TABLE 45 KNEE REPLACEMENT SURGERY MARKET FOR ORTHOPEDIC CLINICS, BY REGION, 2023–2030 (USD MILLION) 109
TABLE 46 KNEE REPLACEMENT SURGERY MARKET, BY REGION, 2023–2030 (USD MILLION) 111
TABLE 47 NORTH AMERICA: MACROECONOMIC OUTLOOK 112
TABLE 48 NORTH AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 113
TABLE 49 NORTH AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 114
TABLE 50 NORTH AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 114
TABLE 51 NORTH AMERICA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 114
TABLE 52 NORTH AMERICA: ORTHOBIOLOGICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 115
TABLE 53 NORTH AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 115
TABLE 54 NORTH AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 116
TABLE 55 US: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 117
TABLE 56 US: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 117
TABLE 57 US: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 118
TABLE 58 US: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 118
TABLE 59 US: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 119
TABLE 60 US: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 119
TABLE 61 CANADA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 120
TABLE 62 CANADA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 120
TABLE 63 CANADA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 120
TABLE 64 CANADA: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 121
TABLE 65 CANADA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 121
TABLE 66 CANADA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 122
TABLE 67 EUROPE: MACROECONOMIC OUTLOOK 123
TABLE 68 EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 123
TABLE 69 EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 124
TABLE 70 EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 124
TABLE 71 EUROPE: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 124
TABLE 72 EUROPE: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 125
TABLE 73 EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 125
TABLE 74 EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 126
TABLE 75 GERMANY: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 127
TABLE 76 GERMANY: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 127
TABLE 77 GERMANY: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 127
TABLE 78 GERMANY: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 128
TABLE 79 GERMANY: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 128
TABLE 80 GERMANY: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 128
TABLE 81 FRANCE: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 129
TABLE 82 FRANCE: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 130
TABLE 83 FRANCE: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 130
TABLE 84 FRANCE: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 131
TABLE 85 FRANCE: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 131
TABLE 86 FRANCE: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 132
TABLE 87 UK: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 133
TABLE 88 UK: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 133
TABLE 89 UK: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 133
TABLE 90 UK: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 134
TABLE 91 UK: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 134
TABLE 92 UK: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 134
TABLE 93 ITALY: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 135
TABLE 94 ITALY: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 135
TABLE 95 ITALY: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 136
TABLE 96 ITALY: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 136
TABLE 97 ITALY: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 137
TABLE 98 ITALY: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 137
TABLE 99 SPAIN: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 138
TABLE 100 SPAIN: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 138
TABLE 101 SPAIN: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 138
TABLE 102 SPAIN: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 139
TABLE 103 SPAIN: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 139
TABLE 104 SPAIN: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 139
TABLE 105 REST OF EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 140
TABLE 106 REST OF EUROPE: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 141
TABLE 107 REST OF EUROPE: ORTHOBIOLOGICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 141
TABLE 108 REST OF EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 142
TABLE 109 REST OF EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 142
TABLE 110 REST OF EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 143
TABLE 111 ASIA PACIFIC: MACROECONOMIC OUTLOOK 144
TABLE 112 ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 146
TABLE 113 ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 146
TABLE 114 ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 147
TABLE 115 ASIA PACIFIC: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 147
TABLE 116 ASIA PACIFIC: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 148
TABLE 117 ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 148
TABLE 118 ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 149
TABLE 119 JAPAN: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 150
TABLE 120 JAPAN: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 150
TABLE 121 JAPAN: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 150
TABLE 122 JAPAN: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 151
TABLE 123 JAPAN: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 151
TABLE 124 JAPAN: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 152
TABLE 125 CHINA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 153
TABLE 126 CHINA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 153
TABLE 127 CHINA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 153
TABLE 128 CHINA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 154
TABLE 129 CHINA: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 154
TABLE 130 CHINA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 155
TABLE 131 INDIA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 156
TABLE 132 INDIA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 156
TABLE 133 INDIA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 156
TABLE 134 INDIA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 157
TABLE 135 INDIA: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 157
TABLE 136 INDIA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 158
TABLE 137 AUSTRALIA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 159
TABLE 138 AUSTRALIA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 159
TABLE 139 AUSTRALIA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 159
TABLE 140 AUSTRALIA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 160
TABLE 141 AUSTRALIA: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 160
TABLE 142 AUSTRALIA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 161
TABLE 143 SOUTH KOREA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 162
TABLE 144 SOUTH KOREA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 145 SOUTH KOREA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 146 SOUTH KOREA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 163
TABLE 147 SOUTH KOREA: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 163
TABLE 148 SOUTH KOREA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 164
TABLE 149 REST OF ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 164
TABLE 150 REST OF ASIA PACIFIC: KNEE IMPLANTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 165
TABLE 151 REST OF ASIA PACIFIC: ORTHOBIOLOGICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 165
TABLE 152 REST OF ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 166
TABLE 153 REST OF ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 166
TABLE 154 REST OF ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 167
TABLE 155 LATIN AMERICA: MACROECONOMIC OUTLOOK 168
TABLE 156 LATIN AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 168
TABLE 157 LATIN AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 169
TABLE 158 LATIN AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 169
TABLE 159 LATIN AMERICA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 169
TABLE 160 LATIN AMERICA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 170
TABLE 161 LATIN AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 170
TABLE 162 LATIN AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 171
TABLE 163 BRAZIL: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 172
TABLE 164 BRAZIL: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172
TABLE 165 BRAZIL: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172
TABLE 166 BRAZIL: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 173
TABLE 167 BRAZIL: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 173
TABLE 168 BRAZIL: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 174
TABLE 169 MEXICO: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 175
TABLE 170 MEXICO: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175
TABLE 171 MEXICO: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175
TABLE 172 MEXICO: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 176
TABLE 173 MEXICO: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 176
TABLE 174 MEXICO: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 177
TABLE 175 REST OF LATIN AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 177
TABLE 176 REST OF LATIN AMERICA: KNEE IMPLANTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 178
TABLE 177 REST OF LATIN AMERICA: ORTHOBIOLOGICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 178
TABLE 178 REST OF LATAM: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 179
TABLE 179 REST OF LATAM: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 179
TABLE 180 REST OF LATAM: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 180
TABLE 181 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 181
TABLE 182 MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET, BY REGION, 2023–2030 (USD MILLION) 181
TABLE 183 MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 182
TABLE 184 MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET,
BY PROCEDURE, 2023–2030 (USD MILLION) 182
TABLE 185 MIDDLE EAST & AFRICA: KNEE IMPLANTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 183
TABLE 186 MIDDLE EAST & AFRICA: ORTHOBIOLOGICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 183
TABLE 187 MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 184
TABLE 188 MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 184
TABLE 189 GCC COUNTRIES: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 185
TABLE 190 GCC COUNTRIES: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 185
TABLE 191 GCC COUNTRIES: ORTHOBIOLOGICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 186
TABLE 192 GCC COUNTRIES: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 186
TABLE 193 GCC COUNTRIES: KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2023–2030 (USD MILLION) 187
TABLE 194 GCC COUNTRIES: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 187
TABLE 195 REST OF MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 188
TABLE 196 REST OF MIDDLE EAST & AFRICA: KNEE IMPLANTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 188
TABLE 197 REST OF MIDDLE EAST & AFRICA: ORTHOBIOLOGICS MARKET, BY TYPE,
2023–2030 (USD MILLION) 189
TABLE 198 REST OF MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 189
TABLE 199 REST OF MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET,
BY END USER, 2023–2030 (USD MILLION) 190
TABLE 200 REST OF MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET,
BY PROCEDURE, 2023–2030 (USD MILLION) 190
TABLE 201 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN KNEE REPLACEMENT SURGERY MARKET, 2022–2025 192
TABLE 202 KNEE REPLACEMENT SURGERY MARKET: DEGREE OF COMPETITION 194
TABLE 203 KNEE REPLACEMENT SURGERY MARKET: REGION FOOTPRINT 201
TABLE 204 KNEE REPLACEMENT SURGERY MARKET: PRODUCT FOOTPRINT 201
TABLE 205 KNEE REPLACEMENT SURGERY MARKET: APPLICATION FOOTPRINT 202
TABLE 206 KNEE REPLACEMENT SURGERY MARKET: PROCEDURE FOOTPRINT 203
TABLE 207 KNEE REPLACEMENT SURGERY MARKET: END-USER FOOTPRINT 203
TABLE 208 KNEE REPLACEMENT SURGERY MARKET: DETAILED LIST OF KEY STARTUPS/SMES 206
TABLE 209 KNEE REPLACEMENT SURGERY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 207
TABLE 210 KNEE REPLACEMENT SURGERY MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MAY 2025 208
TABLE 211 KNEE REPLACEMENT SURGERY MARKET: DEALS, JANUARY 2022–MAY 2025 209
TABLE 212 ZIMMER BIOMET: COMPANY OVERVIEW 211
TABLE 213 ZIMMER BIOMET: PRODUCTS OFFERED 212
TABLE 214 ZIMMER BIOMET: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022−MAY 2025 213
TABLE 215 ZIMMER BIOMET HOLDINGS: DEALS, JANUARY 2022−MAY 2025 214
TABLE 216 STRYKER: COMPANY OVERVIEW 215
TABLE 217 STRYKER: PRODUCTS OFFERED 216
TABLE 218 STRYKER: DEALS, JANUARY 2022−MAY 2025 217
TABLE 219 STRYKER: EXPANSIONS, JANUARY 2022−MAY 2025 217
TABLE 220 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW 219
TABLE 221 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED 220
TABLE 222 JOHNSON & JOHNSON MEDTECH: DEALS, JANUARY 2022−MAY 2025 221
TABLE 223 SMITH+NEPHEW: COMPANY OVERVIEW 222
TABLE 224 SMITH+NEPHEW: PRODUCTS OFFERED 223
TABLE 225 SMITH+NEPHEW: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022−MAY 2025 224
TABLE 226 SMITH+NEPHEW: DEALS, JANUARY 2022−MAY 2025 224
TABLE 227 SMITH+NEPHEW: EXPANSIONS, JANUARY 2022−MAY 2025 224
TABLE 228 B. BRAUN SE: COMPANY OVERVIEW 226
TABLE 229 B. BRAUN SE: PRODUCTS OFFERED 227
TABLE 230 B. BRAUN SE: DEALS, JANUARY 2022−MAY 2025 228
TABLE 231 GLOBUS MEDICAL: COMPANY OVERVIEW 230
TABLE 232 GLOBUS MEDICAL: PRODUCTS OFFERED 231
TABLE 233 GLOBUS MEDICAL: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022−MAY 2025 232
TABLE 234 GLOBUS MEDICAL: DEALS, JANUARY 2022−MAY 2025 232
TABLE 235 ENOVIS: COMPANY OVERVIEW 233
TABLE 236 ENOVIS: PRODUCTS OFFERED 234
TABLE 237 ENOVIS: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022−MAY 2025 236
TABLE 238 ENOVIS: DEALS, JANUARY 2022−MAY 2025 236
TABLE 239 ENOVIS: EXPANSIONS, JANUARY 2022−MAY 2025 237
TABLE 240 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 238
TABLE 241 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 239
TABLE 242 MICROPORT SCIENTIFIC CORPORATION: DEALS, JANUARY 2022−MAY 2025 240
TABLE 243 MEDACTA INTERNATIONAL: COMPANY OVERVIEW 241
TABLE 244 MEDACTA INTERNATIONAL: PRODUCTS OFFERED 242
TABLE 245 MEDACTA INTERNATIONAL: DEALS, JANUARY 2022−MAY 2025 243
TABLE 246 MEDACTA INTERNATIONAL: EXPANSIONS, JANUARY 2022−MAY 2025 243
TABLE 247 MAXX ORTHOPEDICS, INC.: COMPANY OVERVIEW 244
TABLE 248 MAXX ORTHOPEDICS, INC.: PRODUCTS OFFERED 244
TABLE 249 MAXX ORTHOPEDICS, INC.: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022− MAY 2025 244
TABLE 250 MAXX ORTHOPEDICS, INC.: DEALS, JANUARY 2022–MAY 2025 245
TABLE 251 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW 246
TABLE 252 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED 246
TABLE 253 MERIL LIFE SCIENCES PVT. LTD.: EXPANSIONS, JANUARY 2022−MAY 2025 247
TABLE 254 WALDEMAR LINK GMBH & CO. KG: COMPANY OVERVIEW 248
TABLE 255 WALDEMAR LINK GMBH & CO. KG: PRODUCTS OFFERED 248
TABLE 256 EXACTECH, INC.: COMPANY OVERVIEW 249
TABLE 257 EXACTECH, INC.: PRODUCTS OFFERED 249
TABLE 258 EXACTECH, INC.: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022−MAY 2025 250
TABLE 259 EXACTECH, INC.: DEALS, JANUARY 2022−MAY 2025 250
TABLE 260 AMPLITUDE SURGICAL: COMPANY OVERVIEW 251
TABLE 261 AMPLITUDE SURGICAL: PRODUCTS OFFERED 251
TABLE 262 AMPLITUDE SURGICAL: DEALS, JANUARY 2022–MAY 2025 252
TABLE 263 RESTOR3D: COMPANY OVERVIEW 253
TABLE 264 RESTOR3D: PRODUCTS OFFERED 253
TABLE 265 RESTOR3D: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022−MAY 2025 253
TABLE 266 BAUERFEIND: COMPANY OVERVIEW 254
TABLE 267 AK MEDICAL: COMPANY OVERVIEW 255
TABLE 268 DOUBLE MEDICAL TECHNOLOGY INC.: COMPANY OVERVIEW 256
TABLE 269 OLYMPUS CORPORATION: COMPANY OVERVIEW 257
TABLE 270 BIORAD MEDISYS PVT. LTD.: COMPANY OVERVIEW 258
TABLE 271 UNITED ORTHOPEDIC CORPORATION: COMPANY OVERVIEW 259
TABLE 272 ALLEGRA: COMPANY OVERVIEW 260
TABLE 273 TOTAL JOINT ORTHOPEDICS: COMPANY OVERVIEW 260
TABLE 274 THUASNE GROUP: COMPANY OVERVIEW 261
TABLE 275 EMBLA MEDICAL: COMPANY OVERVIEW 262
LIST OF FIGURES
FIGURE 1 KNEE REPLACEMENT SURGERY MARKET AND REGIONAL SCOPE 27
FIGURE 2 KNEE REPLACEMENT SURGERY MARKET: RESEARCH DESIGN 30
FIGURE 3 KNEE REPLACEMENT SURGERY MARKET: MARKET RESEARCH METHODOLOGY 31
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 35
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 36
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 37
FIGURE 7 KNEE REPLACEMENT SURGERY MARKET SIZE ESTIMATION:
APPROACH 1 (COMPANY REVENUE ESTIMATION) 38
FIGURE 8 KNEE REPLACEMENT SURGERY MARKET SIZE ESTIMATION:
BOTTOM-UP APPROACH 39
FIGURE 9 TOP-DOWN APPROACH 40
FIGURE 10 DATA TRIANGULATION 42
FIGURE 11 KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT,
2025 VS. 2030 (USD MILLION) 45
FIGURE 12 KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE,
2025 VS. 2030 (USD MILLION) 46
FIGURE 13 KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 46
FIGURE 14 KNEE REPLACEMENT SURGERY MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 47
FIGURE 15 GEOGRAPHIC SNAPSHOT OF KNEE REPLACEMENT SURGERY MARKET 48
FIGURE 16 RISING PREVALENCE OF KNEE DISEASES AND INCREASING GERIATRIC POPULATION TO DRIVE MARKET 49
FIGURE 17 KNEE IMPLANTS SEGMENT TO REGISTER SIGNIFICANT GROWTH IN
NORTH AMERICAN MARKET DURING FORECAST PERIOD 50
FIGURE 18 TOTAL KNEE REPLACEMENT SEGMENT TO DOMINATE EUROPEAN MARKET DURING FORECAST PERIOD 50
FIGURE 19 HOSPITALS SEGMENT TO LEAD END-USER MARKET IN ASIA PACIFIC DURING FORECAST PERIOD 51
FIGURE 20 JAPAN TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 51
FIGURE 21 KNEE REPLACEMENT SURGERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
FIGURE 22 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 58
FIGURE 23 AVERAGE SELLING PRICE OF KNEE REPLACEMENT SURGERY PRODUCTS,
2024 (USD) 59
FIGURE 24 AVERAGE SELLING PRICE OF KNEE SURGERY PRODUCTS, BY REGION, 2024 (USD) 60
FIGURE 25 KNEE REPLACEMENT SURGERY MARKET: VALUE CHAIN ANALYSIS 62
FIGURE 26 KNEE REPLACEMENT SURGERY MARKET: SUPPLY CHAIN ANALYSIS 63
FIGURE 27 KNEE REPLACEMENT SURGERY MARKET: ECOSYSTEM ANALYSIS 64
FIGURE 28 INVESTMENT AND FUNDING SCENARIO, 2019−2023 (USD MILLION) 65
FIGURE 29 NUMBER OF INVESTOR DEALS IN KNEE REPLACEMENT SURGERY MARKET,
BY KEY PLAYER, 2019−2023 66
FIGURE 30 VALUE OF INVESTOR DEALS IN KNEE REPLACEMENT SURGERY MARKET,
BY KEY PLAYER, 2019–2023 (USD MILLION) 66
FIGURE 31 KNEE REPLACEMENT SURGERY MARKET: PATENT ANALYSIS, 2014–2025 68
FIGURE 32 IMPORT DATA FOR HS CODE 902110, BY COUNTRY,
2021–2024 (USD THOUSAND) 70
FIGURE 33 EXPORT DATA FOR HS CODE 902110, BY COUNTRY,
2021–2024 (USD THOUSAND) 71
FIGURE 34 KNEE REPLACEMENT SURGERY MARKET: PORTER’S FIVE FORCES ANALYSIS 75
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 76
FIGURE 36 KEY BUYING CRITERIA, BY END USER 77
FIGURE 37 KNEE REPLACEMENT SURGERY MARKET: AI USE CASES 79
FIGURE 38 NORTH AMERICA: KNEE REPLACEMENT SURGERY MARKET SNAPSHOT 113
FIGURE 39 ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET SNAPSHOT 145
FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN KNEE REPLACEMENT SURGERY MARKET, 2021−2024 193
FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN KNEE REPLACEMENT SURGERY MARKET, 2024 194
FIGURE 42 RANKING OF KEY PLAYERS IN KNEE REPLACEMENT SURGERY MARKET, 2024 195
FIGURE 43 EV/EBITDA OF KEY VENDORS, 2025 196
FIGURE 44 5-YEAR STOCK BETA OF KEY VENDORS, 2025 196
FIGURE 45 KNEE REPLACEMENT SURGERY MARKET: BRAND/PRODUCT COMPARISON 197
FIGURE 46 KNEE REPLACEMENT SURGERY MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 199
FIGURE 47 KNEE REPLACEMENT SURGERY MARKET: COMPANY FOOTPRINT 200
FIGURE 48 KNEE REPLACEMENT SURGERY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 205
FIGURE 49 ZIMMER BIOMET: COMPANY SNAPSHOT (2024) 212
FIGURE 50 STRYKER: COMPANY SNAPSHOT (2023) 216
FIGURE 51 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2024) 220
FIGURE 52 SMITH+NEPHEW: COMPANY SNAPSHOT (2024) 223
FIGURE 53 B. BRAUN SE: COMPANY SNAPSHOT (2024) 227
FIGURE 54 GLOBUS MEDICAL: COMPANY SNAPSHOT (2024) 231
FIGURE 55 ENOVIS: COMPANY SNAPSHOT (2024) 234
FIGURE 56 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 239
FIGURE 57 MEDACTA INTERNATIONAL: COMPANY SNAPSHOT (2024) 242
FIGURE 58 AMPLITUDE SURGICAL: COMPANY SNAPSHOT (2024) 252
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11